When Disease Strikes Leaders: What Should We Know?

被引:3
|
作者
Mangione, Salvatore [1 ]
机构
[1] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA
关键词
DEMENTIA;
D O I
10.1007/s11606-020-06060-1
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Diseases of heads of state can affect national policy. Yet, cases of cover-up are numerous and involve not only dictatorships but also open and democratic societies. No system of full disclosure is currently in place to ensure that the public has access to all the information needed to establish whether a candidate to the presidency or an elected leader can discharge the powers and duties of the office. Hence, this essay reviews how the illnesses of democratically elected heads of state have changed history; addresses how to ensure greater transparency, so that leaders will not only be unable to conceal incapacitating disabilities, but also be removed from office once impaired; and lastly discusses how illness does not necessarily imply incapacitation, even though separating the two might often be difficult. These are issues of great relevance to national politics and medical ethics. They are particularly important as the 2020 presidential election is underway, and four out of the five leading candidates are well into their 70s.
引用
收藏
页码:3053 / 3056
页数:4
相关论文
共 50 条
  • [21] Cultured meat production: what we know, what we don't know and what we should know
    Olenic, Maria
    Thorrez, Lieven
    ITALIAN JOURNAL OF ANIMAL SCIENCE, 2023, 22 (01) : 749 - 753
  • [22] Chronic prostatitis: what we know, what we do not know, and what we should do!
    Lobel, B
    Rodriguez, A
    WORLD JOURNAL OF UROLOGY, 2003, 21 (02) : 57 - 63
  • [23] Chronic prostatitis: what we know, what we do not know, and what we should do!
    B. Lobel
    A. Rodriguez
    World Journal of Urology, 2003, 21 : 57 - 63
  • [24] What physicians need to know when catastrophe strikes
    Nusbaum, Neil J.
    SOUTHERN MEDICAL JOURNAL, 2007, 100 (11) : 1151 - 1152
  • [25] Glucose lowering and cardiovascular disease: what do we know and what should we do?
    Cheng, Alice Y. Y.
    Leiter, Lawrence A.
    EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2010, 17 : S25 - S31
  • [26] Alzheimer's Disease Costs: What We Know and What We Should Take into Account
    Colucci, Luisa
    Bosco, Massimiliano
    Fasanaro, Angiola Maria
    Gaeta, Giuseppe Lucio
    Ricci, Giovanna
    Amenta, Francesco
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 42 (04) : 1311 - 1324
  • [27] Reflecting on the immunopathology of arthritis associated with inflammatory bowel disease: what do we know and what should we know?
    Amarnani, Abhimanyu
    Thakker, Suchi
    Panush, Richard S.
    CLINICAL RHEUMATOLOGY, 2022, 41 (08) : 2581 - 2588
  • [28] Reflecting on the immunopathology of arthritis associated with inflammatory bowel disease: what do we know and what should we know?
    Abhimanyu Amarnani
    Suchi Thakker
    Richard S. Panush
    Clinical Rheumatology, 2022, 41 : 2581 - 2588
  • [29] What do we know when we know a Language?
    Trabant, Jurgen
    SGUARDO-RIVISTA DI FILOSOFIA, 2009, (01): : 19 - 36
  • [30] What do we know and when do we know it?
    Nicholls, Anthony
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2008, 22 (3-4) : 239 - 255